Tectonic Therapeutic, Inc. Board of Directors

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Dr. Alise S. Reicin M.D., Ph.D.

Dr. Alise S. Reicin M.D., Ph.D.

President, CEO, Secretary & Director

Dr. Peter McNamara Ph.D.

Dr. Peter McNamara Ph.D.

Chief Scientific Officer

Mr. Anthony Muslin M.D.

Mr. Anthony Muslin M.D.

Chief Development Officer

Mr. Daniel Lochner M.B.A.

Mr. Daniel Lochner M.B.A.

Chief Financial Officer

Mr. Barry Rubenstein M.S.

Mr. Barry Rubenstein M.S.

Senior Vice President of People & Culture

John Diener

John Diener

Senior Vice President of Antibody Engineering & Protein Sciences

Dr. Marc Schwabish Ph.D.

Dr. Marc Schwabish Ph.D.

Chief Business Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.